HR 1227 · in committee · significant

Alternatives to PAIN Act

What this bill does

This bill reduces out-of-pocket costs for non-opioid pain medications under Medicare's drug benefit.
Medicare beneficiaries using alternative pain management drugs are affected by lower cost requirements.
The bill eliminates deductibles and prior authorization delays for these medications with no specified funding mechanism.

Generated by claude-haiku-4-5

Community Threads

Started by Cosponsor

01
How would eliminating deductibles and prior authorization for non-opioid pain medications affect Medicare's overall drug spending and premiums for all beneficiaries?
02
What evidence supports that reducing out-of-pocket costs for alternative pain medications would meaningfully increase their use compared to opioids?
03
Which non-opioid pain medications would qualify for deductible elimination, and how would Medicare determine coverage without a specified funding source?

Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.

Sponsor · R-IA-1

Mariannette Miller-Meeks

Citizen cosponsors

In Congress

89/ 435

House Reps cosponsoring

Introduced 2025-02-12

Joining the bill

+ 77 more

Legislative timeline

2025-02-12 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-02-12 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-02-12 · IntroReferral
Introduced in House
2025-02-12 · IntroReferral
Introduced in House

Citizen comments

No comments yet — be the first.